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Abstract
Oligodendrocyte progenitor cells (OPCs) are responsible for generating oligodendro-
cytes, the myelinating cells of the CNS. Life- long myelination is promoted by neuronal 
activity and is essential for neural network plasticity and learning. OPCs are known 
to contact synapses and it is proposed that neuronal synaptic activity in turn regu-
lates their behavior. To examine this in the adult, we performed unilateral injection 
of the synaptic blocker botulinum neurotoxin A (BoNT/A) into the hippocampus of 
adult mice. We confirm BoNT/A cleaves SNAP- 25 in the CA1 are of the hippocampus, 
which has been proven to block neurotransmission. Notably, BoNT/A significantly 
decreased OPC density and caused their shrinkage, as determined by immunolabe-
ling for the OPC marker NG2. Furthermore, BoNT/A resulted in an overall decrease 
in the number of OPC processes, as well as a decrease in their lengths and branching 
frequency. These data indicate that synaptic activity is important for maintaining 
adult OPC numbers and cellular integrity, which is relevant to pathophysiological sce-
narios characterized by dysregulation of synaptic activity, such as age- related cogni-
tive decline, Multiple Sclerosis and Alzheimer's disease.
K E Y W O R D S
BoNT/A, botulinum toxin A, hippocampus, mouse, oligodendrocyte progenitor cell, 
RRID:AB_143165, RRID:AB_2313606, RRID:AB_2340613, RRID:AB_11213678, 
RRID:SCR_002798, RRID:SCR_003070, RRID:SCR_016788, RRID:SCR_017348, SNAP- 25, 
SNARE, Synapse
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1  | INTRODUC TION
Oligodendrocyte progenitor cells (OPCs) are a significant popula-
tion of cells in the adult brain with the fundamental function of life- 
long generation of oligodendrocytes, which is required to myelinate 
new connections formed in response to new life experiences and 
to replace myelin lost through natural “wear and tear” and disease 
(Hill et al., 2018; Young et al., 2013; Zawadzka et al., 2010). OPCs 
are identified by their expression of the proteoglycan NG2 (Cspg4) 
(Ong & Levine, 1999; Stallcup, 1981) and have a complex morphol-
ogy, extending processes to contact neuronal synapses and nodes 
of Ranvier, sensing neuronal glumatergic and GABAergic activity 
(Bergles et al., 2000; Butt et al., 1999; Hamilton et al., 2010; Kukley 
et al., 2007; Lin & Bergles, 2004; Ziskin et al., 2007). Several lines of 
evidence indicate neuronal synaptic activity regulates OPC prolifer-
ation and differentiation (Fannon et al., 2015; Hamilton et al., 2017; 
Mangin et al., 2012; Zonouzi et al., 2015). Optogenetic studies have 
shown that neuronal activity stimulates OPC proliferation and dif-
ferentiation in the cerebral cortex (Gibson et al., 2014). Furthermore, 
motor learning has been shown to drive OPC differentiation, and 
failure to generate new oligodendrocytes impairs myelination of 
newly formed neuronal connections and learning ability (McKenzie 
et al., 2014; Xiao et al., 2016). Hence, it is proposed that decreased 
synaptic activity may result in disruption of OPC regenerative capac-
ity in neurodegenerative diseases, such as Multiple Sclerosis (MS) 
and Alzheimer's disease (AD) (Chacon- De- La- Rocha et al., 2020; 
Rivera et al., 2016; Vanzulli et al., 2020).
The synaptic protein SNAP- 25 is necessary for synaptic vesicle 
fusion and its cleavage by botulinum neurotoxins (BoNTs) blocks neu-
rotransmitter release and synaptic signaling (Caleo & Restani, 2018). 
Developmental myelination is inhibited by ablation of neuronal 
SNAP- 25 either by BoNT/A in cell culture (Wake et al., 2011), or 
genetically in vivo (Korrell et al., 2019), but the effects of synaptic 
activity on adult OPCs remain unclear. In the present study, we 
investigated the effects of prolonged synaptic silencing on adult 
OPCs, by local injection of botulinum neurotoxin A (BoNT/A) into 
the mouse hippocampal CA1 region, which has been demonstrated 
to produce a sustained blockade of synaptic transmission via cleav-
age of the synaptic protein SNAP- 25 (Antonucci et al., 2008; Caleo 
& Restani, 2018; Caleo et al., 2012). Our results demonstrate that 
the synaptic blocker BoNT/A decreases the density and complexity 
of OPCs, leading to overall cellular atrophy. These results indicate 
synaptic activity is important in the long- term maintenance of the 
population of OPCs, with relevance for understanding pathological 
process leading to progressive demyelination.
2  | MATERIAL S AND METHODS
2.1 | Ethics statement
All procedures were performed in compliance with the EU Council 
Directive 2010/63/EU on the protection of animals used for 
scientific purposes, and approved by the Italian Ministry of Health 
(protocol # 346/2013- B). All surgical procedures were performed 
under deep anesthesia and all efforts were made to ameliorate suf-
fering of animals.
2.2 | Animals and tissues
C57BL/6N mice were bred and group housed in the animal facility of 
the CNR Neuroscience Institute in Pisa (Italy). Mice were housed in 
groups of 4 to 10, under a 12 hr light/dark cycle at 21°C, with food 
and water ad libitum, and experimental groups contained a spread 
of sexes. Eight mice aged 11– 12 weeks were anesthetized by intra-
peritoneal injection of Avertin (20 ml/kg, 2,2,2- tribromoethanol so-
lution; Sigma- Aldrich, Cat. #T48402) and mounted in a stereotaxic 
frame (David Kopf Instruments, Tujunga, CA), for injection of BoNT/A 
(n = 4 mice) or sterile vehicle (n = 4 mice). The isolation and purifi-
cation of BoNT/A was performed in house, as previously described 
(Schiavo & Montecucco, 1995; Shone & Tranter, 1995), and its activ-
ity assayed and characterized in the hippocampal model (Antonucci 
et al., 2008; Caleo et al., 2012) (Figure 1). In brief, BoNT/A was iso-
lated from cultures of Clostridium botulinum and purified as 150 kDa 
di- chain neurotoxin, as described by (Shone & Tranter, 1995) and 
(Schiavo & Montecucco, 1995). After purification, toxin was dialyzed 
in 10 mM TrisCl, 150 mM NaCl, pH 6.8 and stored at −80°C until 
use. For hippocampal injections, stock of toxin (50 nM) was thawed 
on ice, diluted to working concentration (1nM, in 2% rat serum albu-
min, PBS) and kept on ice until briefly warming to hand temperature 
immediately prior to brain injections. For hippocampal injections, a 
stereotaxically guided injection of BoNT/A (0.2 µl of a 1 nM solution) 
or vehicle (2% rat serum albumin in PBS) was made into the dorsal 
hippocampus using fine glass micropipettes (at the coordinates, in 
mm with respect to the Bregma, A– P −2.0, M– L 1.5, H 1.7 below 
the dura), as previously characterized (Antonucci et al., 2008; Caleo 
et al., 2012). The experiments were designed in compliance with 
ARRIVE guidelines and no mice were excluded from analyses. In all 
injected animals, recovery was uneventful and no overt behavioral 
abnormalities were observed. Two weeks after injections, mice were 
deeply anesthetized with chloral hydrate and perfused through the 
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heart with freshly prepared 4% paraformaldehyde in 0.1 M phos-
phate buffer (PB), and the brains processed for immunohistochem-
istry (see below).
2.3 | Immunohistochemistry
Brains were post- fixed for 1 hr at 4°C and brain sections (50 μm 
thick) were cut with a freezing microtome and stored at 4°C until 
use in cryoprotectant solution containing 25% sucrose and 3.5% 
glycerol in 0.05 M PBS (all chemicals from Sigma- Aldrich, unless 
otherwise stated), at pH 7.4, prior to immunostaining (for details of 
antibodies, see Table 1). To detect SNAP- 25 cleavage, we used a rab-
bit polyclonal antibody specific for BoNT/A- truncated SNAP- 25 (gift 
from Prof Ornella Rossetto, University of Padua); antibody raised 
against the immunizing sequence CKADSNKTRIDEANQ (aa 184- 
197), affinity purified and previously characterized with full controls 
in our previous studies (Antonucci et al., 2008; Caleo et al., 2012). 
Sections were blocked with 10% donkey serum in PBS containing 
0.25% Triton X- 100 and then incubated overnight at room tempera-
ture with the anti- cleaved SNAP- 25 antibody (1:500 dilution). On the 
following day, sections were incubated with anti- rabbit Rhodamine 
Red X, 1:500 (Jackson ImmunoResearch Labs Cat# 711- 295- 152, 
RRID:AB_2340613), washed in PBS, counterstained with Hoechst 
33342 (Thermo Fisher Scientific Cat#62249). For NG2 immunostain-
ing, sections were blocked with 0.5% bovine serum albumin (BSA) 
for 1- 2h, washed three times in PBS, and incubated overnight in the 
antibody solution which comprised of the primary antibody rabbit 
anti- NG2, 1:500 (Millipore Cat# AB5320, RRID:AB_11213678), di-
luted in blocking solution containing 0.25% Triton- X. Tissues were 
then washed three times in PBS and incubated for 1– 2h with ap-
propriate fluorochrome secondary antibody, diluted at 1:500 in 
blocking solution (Alexa Fluor 488- AffiniPure Goat Anti- Rabbit IgG 
(H+L), Thermo Fisher Scientific Cat# A- 11008, RRID:AB_143165), or 
biotinylated secondary antibody, diluted at 1:200 in blocking solu-
tion (Biotinylated Goat Anti- Rabbit IgG (H+L), Vector Laboratories 
Cat# BA- 1000, RRID:AB_2313606). Finally, sections were washed 
three times with PBS before being mounted on glass slides and cov-
ered with mounting medium and glass coverslips ready for imaging.
2.4 | Imaging and analysis
Immunofluorescence images were captured using a Zeiss Axiovert 
LSM 710 VIS40S confocal microscope and maintaining the acqui-
sition parameters constant to allow comparison between samples 
within the same experiment. Acquisition of images for cell counts 
was performed with ×20 objective. Images for OPC reconstruction 
were taken using ×100 objective and capturing z- stacks formed by 
80– 100 single plains with an interval of 0.3 µm. All analyses were 
performed by a person who was blind to experimental conditions 
and no exclusion criteria were applied. OPC cell counts were per-
formed manually on images using a constant field of view (FOV) of 
200 µm × 200 µm centered on the CA1 area, and data expressed as 
OPC density per mm2; data from two sections per mouse were aver-
aged, to provide a final n = 4 mice per treatment group, on which 
statistics were performed. To determine the process domains (cell 
coverage) of OPCs, chromogenic NG2 immunostained sections 
were examined on an Olympus dotSlide digital slide scanning sys-
tem based on a BX51 microscope stand with an integrated scan-
ning stage and Olympus CC12 color camera, and the cell coverage 
of OPCs was measured using ImageJ by drawing a line around the 
entire cell process field and the area within the line was measured 
using ImageJ (RRID:SCR_003070), and data were expressed as µm2; 
F I G U R E  1   BoNT/A cleaves SNAP- 25 in the hippocampus. Representative fluorescence micrographs of coronal sections of the adult 
mouse hippocampus illustrating the CA1 area following stereotaxical injection of BoNT/A or vehicle. Sections are immunolabeled with an 
antibody specific for BoNT/A- truncated SNAP- 25 (red), which has been thoroughly characterized in previous studies (Antonucci et al., 2008; 
Caleo et al., 2012), and counterstained with Hoechst nuclear dye. Scale bar = 100 µm; images representative of two sections each from four 
animals
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data from two sections per mouse were averaged, to provide a final 
n = 4 mice per treatment group, on which statistics were performed. 
For detailed morphological analysis of single OPCs, cells were drawn 
using Neurolucida 360 (MBF Bioscience, RRID:SCR_016788), and 
their morphology was analyzed using Neurolucida 360 explorer 
(MBF Bioscience, RRID:SCR_017348) for measurements of the 
number of processes per cell, process lengths, number of process 
terminals (end points), and number of nodes (branch points); three 
cells were drawn from the center of the CA1 field in one section per 
mouse (12 cells from 4 mice per treatment group), and data were 
averaged in each mouse, to provide a final n = 4 mice per treatment 
group, on which statistics were performed. Sholl analysis was per-
formed on the same cells, using a 5µm interval between Sholl shells 
(n = 12 cells from fours mice in each experimental group).
2.5 | Statistical analysis
All data are represented as mean ± SD. Data sets were analyzed statis-
tically by Graphpad Prism 6.0 software (Graphpad, San Diego, USA, 
RRID:SCR_002798). Statistical differences between two parametric 
samples were measured by the unpaired two tailed Student's t test, 
and statistical differences of multiple parameters were assessed by 
two- way ANOVA with Sidak's post hoc multiple comparisons test. 
Statistics, actual p values, when significant, and number of samples 
are reported in the text. Data were analyzed by a person who was 
blind to experimental conditions and no exclusion criteria were ap-
plied. Statistical significance in the figures is indicated as: *p ≤ 0.05; 
**p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001, ns = p > 0.05.
3  | RESULTS
3.1 | The synaptic blocker BoNT/A causes a 
reduction in OPC numerical density and size in the 
CA1 region of the hippocampus
The long- term effects of synaptic silencing on adult OPCs have not 
been previously studied. We addressed this by injecting adult mice 
into the left hippocampus with BoNT/A (1 nM solution, 0.2 µl), which 
causes persistent blockade of hippocampal synaptic activity for up 
to 120 days (Antonucci et al., 2008; Caleo et al., 2012). The hip-
pocampus was analyzed 2 weeks post- injection and we confirmed 
that BoNT/A mediates long- term SNAP- 25 cleavage in the CA1 
area of inoculated side (Figure 1), which has been detailed compre-
hensively in earlier studies, by immunohistochemistry and western 
F I G U R E  2   Effect of synaptic silencing with BoNT/A on adult hippocampal OPC in vivo. Analysis of OPCs in hippocampus following 
injection with BoNT/A to silence synaptic activity, or vehicle in controls. (a– c) Immunofluorescence labeling for NG2 (green) and counterstain 
with Hoechst nuclear dye (blue), illustrating the overall distribution of OPCs in the CA1 area of the hippocampus following injection of 
vehicle (a) or BoNT/A (b), together with box– whisker plots of the numerical density of OPCs in the CA1 (c); scale bars = 50 µm; data were 
averaged from two sections per mouse to provide a mean ± SEM from n = 4 mice per treatment group; p = 0.0267, unpaired t test. (d- f) High 
magnification of individual chromogenic NG2 immunolabeled OPCs in the CA1 area of the hippocampus illustrating their process domains 
(broken lines) following injection of vehicle (d) or BoNT/A (e), together with box– whisker plots of OPC cell domains (f); scale bars = 20 µm; 
data were averaged from two sections per mouse (37 cells for vehicle, 43 cells for BoNT/A), to provide a mean ± SEM from n = 4 animals per 
treatment group; p =0.0003, unpaired t test
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blot (Antonucci et al., 2008; Caleo et al., 2012). Next, we used im-
munolabeling for NG2 to identify OPCs (Butt et al., 1999), and we 
focused on the CA1 area as OPCs had been previously shown to 
form synapses with neurones and respond to synaptic signaling in 
this area (Bergles et al., 2000; Lin & Bergles, 2004). Confocal images 
demonstrate an evident decrease in NG2 immunostaining 14 days 
after BoNT/A injection (Figure 2a), compared to controls injected 
with vehicle (Figure 2b). Quantification confirmed OPC numerical 
density was decreased following BoNT/A injection compared to 
controls (Figure 2c; unpaired t test, t = 2.918, df = 6, p = 0.0267; 
data from two sections per mouse were averaged, to provide a final 
n = 4 mice per treatment group). Moreover, mapping the process do-
mains of individual OPCs (Figure 2d,e) demonstrated these were sig-
nificantly reduced following synaptic silencing (Figure 2f; unpaired t 
test, t = 7.651, df = 6, p = 0.0003; data from 37 cells for vehicle and 
43 cells for BoNT/A from two sections per mouse were averaged, 
to provide a final n = 4 mice per treatment group). The data show 
that the synaptic blocker BoNT/A results in a decline in the overall 
number of OPC and those that persist display a marked shrinkage.
3.2 | BoNT/A decreases the morphological 
complexity of OPCs
Adult OPCs respond to pathology by changes in their morphol-
ogy (Butt et al., 2002), and in the adult hippocampus they react to 
toxic activation of glutamatergic receptors by extending a greater 
number of short process (Ong & Levine, 1999). We therefore ex-
amined OPC morphology in detail using Neurolucida (Figure 3) and 
Sholl analysis (Figure 4). Overall, OPCs had a characteristic complex 
morphology in vehicle- injected controls, with on average 12 primary 
processes that extended radially for 50– 100 µm from a central cell 
body (Figure 3a). In comparison, OPCs displayed overall atrophy 
following BoNT/A injection, with an evident decrease in cellular 
complexity (Figure 3b); the shrinkage of the OPC process field fol-
lowing BoNT/A treatment is amplified in the y- plane (upper insets, 
Figure 3a,b), and in the x- plane OPCs in controls are seen to have a 
dense network of branching processes, which is stunted following 
synaptic silencing (lower insets, Figure 3a,b). Multiple parameters of 
process complexity were quantified (Figure 3c– e); data were from 
three cells drawn from the center of the CA1 field in one section 
per mouse, which was averaged in each mouse, to provide a final 
n = 4 mice per treatment group. There were significant decreases 
in the number of processes extending from the cell body follow-
ing BoNT/A injection, ranging from 2 to 12, compared to 8– 25 in 
controls (Figure 3c; unpaired t test, p = 0.0448, t = 2.528, df = 6, 
n = 4 animals in each group), together with significant decreases in 
the length of processes from each cell (Figure 3d; unpaired t test, 
p = 0.0116, t = 3.582, df = 6, n = 4 animals in each group), as well as 
the number of process terminals, or end points (Figure 3e; unpaired 
t test, p = 0.0280, t = 2.881, df = 6, n = 4 animals in each group), 
and the number of branch points along processes (nodes) (Figure 3f; 
unpaired t test, p = 0.0277, t = 2.891, df = 6, n = 4 animals in each 
group). The results indicate a primary effect of BoNT/A on cellular 
branching and this was examined further by Sholl analysis (Figure 4). 
The data indicate that following synaptic silencing the most marked 
changes in OPC processes were within 20– 30 μm of the cell body, 
with significant decreases in the number of nodes, or branch points 
(Figure 4b; two- way ANOVA followed by Sidak's multiple compari-
sons tests, F(13, 308) = 90.49, p < 0.0001, n = 12 cells from four 
animals in each group), as well as the number of process terminals 
(Figure 4c; two- way ANOVA followed by Sidak's multiple compari-
sons tests, F(13, 308) = 98.22, p < 0.0001, n = 12 cells from four 
animals in each group), and the lengths of processes (Figure 4d; two- 
way ANOVA followed by Sidak's multiple comparisons tests, F(13, 
308) = 182.1, p < 0.0001, n = 12 cells from four animals in each 
group). In addition, we analyzed the processes length in the different 
branch orders, identifying that synaptic silencing primarily caused 
shrinkage of the distal branches, and the maximum branch order 
was decreased to 13 compared to 15 in controls (Figure 4e; two- 
way ANOVA followed by Sidak's multiple comparisons tests, F(15, 
352) = 94.80, p < 0.0001, n = 12 cells from four animals in each 
group). Although the possibility of bias may have been introduced 
in the Neurolucida and Sholl analyses of a relatively small number of 
OPCs, it is evident that OPCs were shrunken following BoNT/A, with 
very little variation, and these measurements are corroborated by 
the atrophy of OPC process domains based on a much larger num-
ber of cells demonstrated in Figure 2. Together, the morphological 
analyses show that OPC shrinkage is a key feature following synaptic 
silencing with BoNT/A and is mainly due to process retraction and an 
evident decrease in branching.
4  | DISCUSSION
An important feature of OPCs is that they form synapses with neu-
rones and sense neuronal synaptic activity (Bergles et al., 2000). 
Here, we show that BoNT/A, which silences synaptic activity in the 
hippocampus, results in a decrease in OPC numbers and cellular at-
rophy. Notably, similar changes in OPCs are associated with synaptic 
dysregulation in AD- like pathology in mice (Chacon- De- La- Rocha 
et al., 2020; Vanzulli et al., 2020). The results support a role for 
synaptic signaling in maintaining adult OPC numbers and integrity, 
which is relevant to neuropathologies in which neuronal activity is 
altered, such as AD, MS, and traumatic injury, as well as age- related 
cognitive decline.
BoNT/A is a member of the family of botulinum neurotoxins 
(BoNTs A- G) that inhibit neurotransmission by blocking vesicu-
lar neurotransmitter release (Caleo & Restani, 2018). BoNTs enter 
presynaptic terminals mainly via activity- dependent synaptic endo-
cytosis and cleave proteins of the SNARE complex, which is neces-
sary for synaptic vesicle fusion (Verderio et al., 2006). It has been 
demonstrated that infusion of BoNT/A into the mouse hippocam-
pus cleaves SNAP- 25 and prevents neuronal synaptic activity in the 
CA1 area (Antonucci et al., 2008). It is possible that BoNT/A cleaves 
SNAP- 25 in OPCs, but in the hippocampus SNAP- 25 is concentrated 
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F I G U R E  3   Effects of synaptic silencing with BoNT/A on OPC morphology in the adult hippocampus. Confocal images of hippocampus 
sections were immunolabeled for NG2 following injection with BoNT/A to silence synaptic activity, or vehicle in controls. (a, b) Confocal 
images were analyzed using Neurolucida 360 (MBF Bioscience), to generate 3D images (main panels in a, b); insets illustrate the cell in the 
x- and y- planes. (c– f) Box– whisker plots of the number of processes per cell (c), process lengths (d), number of process terminals, or end 
points (e), and the number of branch points, or nodes (f). Data were from three cells drawn from the center of the CA1 field in one section 
per mouse, which was averaged in each mouse, to provide a mean ± SEM from n = 4 animals per treatment group; p values as indicated, from 
unpaired t tests
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in neuronal terminals and is largely absent from glial processes 
(Schubert et al., 2011), and transcriptomic data indicate that SNAP- 
25 is barely detectable in OPCs and other glia, compared to neurons 
(Figure S1; (Zhang et al., 2014)). Glia can express SNAP- 23 (Feldmann 
et al., 2009; Hepp et al., 1999; Schardt et al., 2009; Schubert 
et al., 2011), but BoNT/A acts mainly on SNAP- 25 and not SNAP- 23 
(Sikorra et al., 2016). In addition, it has been shown that BoNT/A 
has little effect on astrocytes (Rojewska et al., 2018), or microglia 
(Caleo et al., 2012), and the primary effect of BoNT/A is on synaptic 
signaling, with little evidence of axonal disruption (Antonucci et al., 
2008; Caleo et al., 2012). It is not discounted that BoNT/A could act 
on synaptic transmission by OPCs (Hamilton et al., 2010), or have 
other effects on OPCs unrelated to synaptic transmission, but the 
results of the present study are consistent with BoNT/A acting to 
silence neuronal synapses and cause a decrease in OPC numbers 
and cell shrinkage, resulting in marked loss of overall coverage of the 
hippocampus by OPCs.
Our data demonstrate that BoNT/A treatment resulted in a 
decrease in OPC numbers, indicating that OPC self- renewal is 
dependent on synaptic signaling. These findings support previous 
F I G U R E  4   Sholl analysis of OPC process morphology in the adult hippocampus following synaptic silencing with BoNT/A. (a) Isosurface 
rendering to illustrate 3D morphology of OPCs (generated with Volocity software, PerkinElmer), obtained following NG2 immunolabeled 
cells in CA1 area of the hippocampus following injection of BoNT/A (ai) or vehicle (aii). The schematic representation in (aiii) illustrates 
parameters measured, where the concentric circles (termed Sholl shells) are placed at 5 μm apart, with the cell body in the middle (yellow 
lines in ai, aii); the points of process branching are termed nodes (blue dots), and the points where the processes intersect the Sholl shells 
are termed intersections (green dots) (adapted from Sholl (1953) and Rietveld et al. (2015)). (b– e) Graphs of the number of nodes or branch 
points (b), number of process terminals or end points (c), processes lengths (d), and length of processes of different branch orders (e). Data 
are mean ± SEM; n = 12 cells from four animals per group (three cells per section, taken from the center of the CA1 field); p values as 
indicated, from two- way ANOVA followed by Sidak's multiple comparisons test
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studies showing OPC proliferation is respectively increased or 
decreased when neuronal electrical activity is stimulated (Gibson 
et al., 2014) or blocked (Barres & Raff, 1993). The decrease in OPCs 
following BoNT/A indicates their population was not replenished 
by self- renewal, although further studies to measure cell prolifer-
ation are required to confirm this. A novel finding of our study is 
that BoNT/A caused shrinkage of adult OPC in vivo, with a marked 
retraction of distal processes and decreased branching. A simi-
lar reduction in OPC process extension and branching has been 
reported in vitro in postnatal cerebellar slices following blockade 
of neuronal electrical activity and glutamate receptors (Fannon 
et al., 2015). This is in comparison to the response of OPCs to 
CNS insults, which is usually marked by increased process branch-
ing to give OPCs a fibrous appearance (Butt et al., 2002; Levine 
et al., 2001). Time- lapse imaging demonstrates that NG2+ OPCs 
processes are highly motile and respond rapidly to changes in their 
environment (Hughes et al., 2013). Hence, it is possible that OPC 
processes are retracted from silent synapses following BoNT/A 
treatment, resulting in decreased coverage by OPCs, which is 
comparable to early atrophy of OPCs observed in mouse models 
of AD that are characterized by synaptic dysregulation (Chacon- 
De- La- Rocha et al., 2020; Vanzulli et al., 2020). The overall extent 
of synaptic disruption in neuropathology is unlikely to be as ex-
tensive as that of the hippocampus following BoNT/A injection, 
and the changes observed in the present study are more likely to 
reflect those that occur focally within lesions. Indeed, changes in 
OPC morphology are characteristic of neuropathology in human 
AD and MS, as well as mouse models of these diseases (Butt & 
Dinsdale, 2005; Dong et al., 2018; Levine & Reynolds, 1999; Li 
et al., 2013; Nielsen et al., 2013; Reynolds et al., 2002; Zhang 
et al., 2019). These data support evidence that synaptic signaling 
regulates adult OPC morphology and the maintenance of their 
numbers.
The effects of BoNT/A on hippocampal OPCs may be due 
mainly to blockade of glutamatergic synapses, since BoNT/A has 
been shown to act preferentially on excitatory synapses (Antonucci 
et al., 2008; Caleo et al., 2012), which are contacted by OPCs 
(Bergles et al., 2000). Furthermore, neurotransmitters released at 
synapses or along axons would also activate non- synaptic recep-
tors on adult OPCs through what is termed volume transmission 
(Kula et al., 2019; Vélez- Fort et al., 2010; Hamilton et al., 2010), 
which would also be blocked by BoNT/A. Glutamatergic signal-
ing has been shown to promote OPC proliferation (Chen et al., 
2018; Wake et al., 2011), hence blockade of glutamate release by 
BoNT/A would result in the observed decline in OPC numbers. To 
confirm this unequivocally will require comprehensive electro-
physiological, immunohistochemical, EM, cell proliferation, and 
fate- mapping studies. Nonetheless, we demonstrate that BoNT/A 
causes cleavage of SNAP- 25 in our model (Figure 1), which is 
essential for synaptic vesicular release of glutamate (Caleo & 
Restani, 2018). In contrast, electrophysiological and EM studies 
indicate BoNT/A does not affect GABAergic synapses when used 
in the hippocampal model (Antonucci et al., 2008; Caleo et al., 
2012), which has been explained by the fact that SNAP- 25 is ex-
pressed only at very low levels in GABAergic synapses (Verderio 
et al., 2004). Furthermore, although OPCs in the hippocampus 
receive synaptic inputs from GABAergic neurones (Bergles et al., 
2000; Lin & Bergles, 2004), their blockade is reported to increase 
OPC numbers in vitro in cortical slices (Hamilton et al., 2017; 
Zonouzi et al., 2015), which is opposite to that observed following 
synaptic silencing. Also, as noted above, OPC disruption following 
BoNT/A in vivo is mirrored by blockade of glutamatergic signaling 
in vitro in cerebellar slices (Fannon et al., 2015). Thus, the balance 
of evidence indicates excitatory synaptic signaling plays an im-
portant role in maintaining OPC numbers and integrity in the adult 
hippocampus.
5  | CONCLUSIONS
This study demonstrates that the synaptic blocker BoNT/A has a 
major negative impact on adult OPCs, which have the fundamen-
tal function of life- long generation of oligodendrocytes. It will be 
of considerable interest in future studies to determine whether 
synaptic blockade has longer term effects on myelination that is 
required for the formation of new neuronal connections and learn-
ing (McKenzie et al., 2014; Xiao et al., 2016). Notably, disruption 
of OPCs has been shown to result in impaired myelination in aging 
(Neumann et al., 2019; Rivera et al., 2021), and this is a key factor 
in the age- related decline in cognitive function (Bartzokis, 2004), as 
well as the failure of remyelination in chronic MS (Sanai et al., 2016), 
and the accelerated loss of myelin observed in AD (Nasrabady et al., 
2018; Vanzulli et al., 2020). In conclusion, disruption of OPCs fol-
lowing synaptic blockade in the hippocampus is relevant to cogni-
tive function and neuropathologies where there is dysregulation of 
neuronal synaptic activity.
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